1. Home
  2. PCRX vs TMP Comparison

PCRX vs TMP Comparison

Compare PCRX & TMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PCRX
  • TMP
  • Stock Information
  • Founded
  • PCRX 2006
  • TMP 1836
  • Country
  • PCRX United States
  • TMP United States
  • Employees
  • PCRX N/A
  • TMP N/A
  • Industry
  • PCRX Biotechnology: Pharmaceutical Preparations
  • TMP Major Banks
  • Sector
  • PCRX Health Care
  • TMP Finance
  • Exchange
  • PCRX Nasdaq
  • TMP Nasdaq
  • Market Cap
  • PCRX 1.2B
  • TMP 1.0B
  • IPO Year
  • PCRX 2011
  • TMP N/A
  • Fundamental
  • Price
  • PCRX $26.86
  • TMP $68.70
  • Analyst Decision
  • PCRX Buy
  • TMP Buy
  • Analyst Count
  • PCRX 6
  • TMP 2
  • Target Price
  • PCRX $30.00
  • TMP $69.00
  • AVG Volume (30 Days)
  • PCRX 592.7K
  • TMP 38.5K
  • Earning Date
  • PCRX 11-05-2025
  • TMP 10-24-2025
  • Dividend Yield
  • PCRX N/A
  • TMP 3.57%
  • EPS Growth
  • PCRX N/A
  • TMP 457.47
  • EPS
  • PCRX N/A
  • TMP 5.55
  • Revenue
  • PCRX $705,848,000.00
  • TMP $306,372,000.00
  • Revenue This Year
  • PCRX $7.36
  • TMP $16.18
  • Revenue Next Year
  • PCRX $10.07
  • TMP $6.47
  • P/E Ratio
  • PCRX N/A
  • TMP $12.51
  • Revenue Growth
  • PCRX 2.25
  • TMP 39.13
  • 52 Week Low
  • PCRX $13.04
  • TMP $54.16
  • 52 Week High
  • PCRX $27.64
  • TMP $79.01
  • Technical
  • Relative Strength Index (RSI)
  • PCRX 61.04
  • TMP 51.51
  • Support Level
  • PCRX $25.63
  • TMP $68.59
  • Resistance Level
  • PCRX $27.11
  • TMP $70.46
  • Average True Range (ATR)
  • PCRX 0.96
  • TMP 1.30
  • MACD
  • PCRX -0.05
  • TMP -0.25
  • Stochastic Oscillator
  • PCRX 68.80
  • TMP 5.34

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

About TMP Tompkins Financial Corporation

Tompkins Financial Corp is a Financial Holding Company. It has three business segments, consisting of banking, insurance and wealth management. It offers various products and services, including commercial and consumer banking, leasing, trust and investment management, financial planning and wealth management, and insurance. Insurance is comprised of property and casualty insurance services and employee benefit consulting. Wealth management activities include the results of the company's trust, financial planning, and wealth management services. The company generates majority of its revenue from Banking segment.

Share on Social Networks: